CSRC approves Changyu Group's application for an IPO on the Shanghai Stock Exchange Main Board.
On January 9th, the China Securities Regulatory Commission issued the "Approval for the Initial Public Offering of Shares by Changyu Holdings Group Limited".
On January 9th, the China Securities Regulatory Commission issued the reply on approving the initial public offering of shares by Chongyang Holdings Group Co., Ltd. It is reported that Chongyang Group plans to be listed on the Shanghai Stock Exchange main board, with Southwest as its sponsoring institution, aiming to raise 700 million yuan.
According to the prospectus, Chongyang Group is mainly engaged in research, development, production, and sales of zirconium products, special nylon products, and fine chemical products. Its main products include zirconium oxychloride, zirconium carbonate, zirconium oxide, nano composite zirconium oxide, special nylon, long carbon chain diacids, long carbon chain diols, and long carbon chain dimethyl ester.
The company's products are widely used in sectors such as automotive, communications, consumer electronics, high-performance ceramics, and medical fields. The company has established a relatively complete sales network and service system, with its products sold in mainland China, Europe, the United States, Japan, South Korea, India, Southeast Asia, and other countries and regions. Zirconium products and special nylon products are the main sources of the company's revenue and profits.
Related Articles

SF Diamond Co., Ltd. (300179.SZ) several shareholders plan to collectively reduce their holdings by no more than 1.01% of the shares.

Liaoning He Eye Hospital Group (301103.SZ) shareholder Advanced Manufacturing Fund intends to reduce its shareholding by no more than 1.97%

Shanghai Huide Science & Technology (603192.SH) Stock issuance request approved by the registration approval.
SF Diamond Co., Ltd. (300179.SZ) several shareholders plan to collectively reduce their holdings by no more than 1.01% of the shares.

Liaoning He Eye Hospital Group (301103.SZ) shareholder Advanced Manufacturing Fund intends to reduce its shareholding by no more than 1.97%

Shanghai Huide Science & Technology (603192.SH) Stock issuance request approved by the registration approval.






